Effects of TORC1 Inhibition during the Early and Established Phases of Polycystic Kidney Disease

• Michelle H. T. Ta,

  Affiliation Michael Stern Translational Laboratory for Polycystic Kidney Disease, Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia

  ⨯
• Kristina G. Schwensen,

  Affiliation Michael Stern Translational Laboratory for Polycystic Kidney Disease, Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia

  ⨯
• Sheryl Foster,

  Affiliations Department of Radiology, University of Sydney at Westmead Hospital, Sydney, Australia, Faculty of Health Sciences, University of Sydney, Sydney, Australia

  ⨯
• Mayuresh Korgaonkar,

  Affiliation Brain Dynamics Centre, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia

  ⨯
• Justyna E. Ozimek-Kulik,

  Affiliation Department of Biomedical Science, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia

  ⨯
• Jacqueline K. Phillips,

  Affiliation Department of Biomedical Science, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, Australia

  ⨯
• Anthony Peduto,

  Affiliation Department of Radiology, University of Sydney at Westmead Hospital, Sydney, Australia

  ⨯
• Gopala K. Rangan

  * E-mail: g.rangan@sydney.edu.au

  Affiliations Michael Stern Translational Laboratory for Polycystic Kidney Disease, Centre for Transplant and Renal Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia, Department of Renal Medicine, Westmead Hospital, Western Sydney Local Heath District, Westmead, Sydney, Australia

  ⨯